Trending stocks

Rilbbph reports 26.3% revenue decline in FY2016 and 5.8 pp EBITDA Margin growth from 10.0% to 15.8%

22-04-2016 • About Rilbbph ($RILBBPH) • By InTwits

Rilbbph reported FY2016 financial results today. Here are the key drivers of the company's long term financial model:
  • Rilbbph has high CAPEX intensity: 5 year average CAPEX/Revenue was 12.2%. At the same time it's in pair with industry average of 10.7%
  • CAPEX is quite volatile: ₹496,620m in FY2016, ₹633,640m in FY2015, ₹600,870m in FY2014, ₹307,260m in FY2013, ₹163,810m in FY2012
  • The company has business model with low profitability: ROIC is 7.3%
Below you can find a comprehensive analysis of the key data driving the company's performance and the stock price.

Revenue and profitability


Rilbbph's Revenue dropped on 26.3%. Revenue decline was accelerating on average at -14.7 pp per annum in FY2012-FY2016. Revenue decline happened at the same time with EBITDA margin expansion. EBITDA Margin increased on 5.8 pp from 10.0% to 15.8% in FY2016. During FY2012-FY2016 EBITDA Margin bottomed in FY2014 at 8.1% and was growing since that time.

Net Income margin increased on 3.7 pp from 6.3% to 10.0% in FY2016. During FY2012-FY2016 Net Income margin bottomed in FY2014 at 5.2% and was growing since that time.

Investments (CAPEX, working capital and M&A)


In FY2016 the company had CAPEX/Revenue of 18.0%. Rilbbph showed fast CAPEX/Revenue growth of 10.2 pp from 7.7% in FY2013 to 18.0% in FY2016. Average CAPEX/Revenue for the last three years was 16.2%. The company has spent a lot to CAPEX (114% of EBITDA) which didn't stop revenue from falling. CAPEX as a % of Revenue grew at 3.6 pp per annum in FY2012-FY2016.

Return on investment


The company operates at low ROIC (7.3%) and ROE (12.0%). ROIC showed almost no change in FY2016. ROE increased slightly on 0.66 pp from 11.3% to 12.0% in FY2016. During the last 5 years ROIC bottomed in FY2015 at 7.0%. During the last 5 years ROE bottomed in FY2015 at 11.3%.

Leverage (Debt)


Company's Net Debt / EBITDA is 3.9x and Debt / EBITDA is 4.2x. Net Debt / EBITDA decreased on 0.029x from 3.9x to 3.9x in FY2016. Debt jumped on 13.0% while cash dropped on 14.8%. Net Debt/EBITDA grew at 0.6x per annum in the last 5 years.

Rilbbph has short term refinancing risk: cash is only 26.8% of short term debt.

Financial and operational results


Rilbbph ($RILBBPH) key annual financial indicators

mln. INR201220132014201520162016/2015
P&L
Revenue3,585,0103,970,6204,344,6003,754,3502,765,440-26.3%
EBITDA347,630329,880350,300376,010437,07016.2%
Net Income197,240208,790224,930235,660276,30017.2%
Balance Sheet
Cash338,400372,670379,090125,200106,710-14.8%
Short Term Debt270,950362,590377,420400,860398,180-0.7%
Long Term Debt653,520709,6001,010,1601,207,7701,420,00017.6%
Cash flow
Capex163,810307,260600,870633,640496,620-21.6%
Ratios
Revenue growth34.9%10.8%9.4%-13.6%-26.3%
EBITDA growth-8.0%-5.1%6.2%7.3%16.2%

EBITDA Margin9.7%8.3%8.1%10.0%15.8%5.8%
Net Income Margin5.5%5.3%5.2%6.3%10.0%3.7%
CAPEX, % of revenue4.6%7.7%13.8%16.9%18.0%1.1%

ROIC8.5%7.6%7.3%7.0%7.3%0.4%
ROE12.2%11.9%11.8%11.3%12.0%0.7%
Net Debt/EBITDA1.7x2.1x2.9x3.9x3.9x-0.0x

Peers in


Below you can find Rilbbph benchmarking vs. other companies in industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Rane Engine Valve ($RANENGIN)6.5%-14.4%-1.2%49.3%-
Indbulbbph ($INDBULBBPH)-3.2%-6.5%33.5%49.2%-
Monetbbph ($MONETBBPH)22.3%3.7%11.6%40.8%-
Asleyf ($ASLEYF)15.5%-3.3%-8.0%33.6%-
Bharat Rasayan ($BHARATRA)51.3%32.1%92.7%21.4%-
 
Median (16 companies)17.7%11.1%3.5%9.2%-
Rilbbph ($RILBBPH)-10.8%9.4%-13.6%-26.3%


Top companies by Gross margin, %

Top  FY2012 FY2013 FY2014 FY2015 FY2016
Jenson & Nicholson Financial Services ($JNFSL)0.0%0.0%0.0%0.0%0.0%
Bombay Drugs & Pharmas ($BOMDRDM)0.0%0.0%0.0%0.0%0.0%
Southern Herbals ($SOUTHNHE)0.0%0.0%0.0%0.0%0.0%
Tafnccpeq ($TAFNCCPEQ)0.0%0.0%0.0%0.0%0.0%
 
Median (4 companies)0.0%0.0%0.0%0.0%0.0%


Top companies by EBITDA margin, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Oswal Chemicals & Fertilizers ($OSWALCHEM)---53.4%-
Kaleconbbph ($KALECONBBPH)27.7%44.3%43.5%37.9%-
Paushak ($PAUSHAK)---25.6%-
The United Nilgiri Tea Estates Company ($UNITEDTEA)---24.7%-
Indbulbbph ($INDBULBBPH)36.7%34.6%29.5%23.5%-
 
Median (19 companies)16.0%16.6%16.9%11.0%9.6%
Rilbbph ($RILBBPH)9.7%8.3%8.1%10.0%15.8%


Top companies by CAPEX/Revenue, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Monetbbph ($MONETBBPH)131.4%5.2%139.2%89.2%-
Jklakbbph ($JKLAKBBPH)28.5%28.8%24.6%23.6%-
Gkw ($GKW)---15.5%-
Paushak ($PAUSHAK)---12.3%-
The United Nilgiri Tea Estates Company ($UNITEDTEA)---8.8%-
 
Median (16 companies)9.9%5.2%3.8%5.0%0.5%
Rilbbph ($RILBBPH)4.6%7.7%13.8%16.9%18.0%


Top companies by ROIC, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Kaleconbbph ($KALECONBBPH)-89.0%103.8%81.0%-
Bharat Rasayan ($BHARATRA)22.1%13.7%21.9%26.1%-
Uplbbph ($UPLBBPH)17.1%15.9%18.2%22.1%-
Rane Brake Lining ($RANEBRAKE)14.1%7.9%11.1%12.8%-
Merckbbph ($MERCKBBPH)21.3%13.1%8.6%10.6%-
 
Median (27 companies)9.3%5.8%5.3%3.1%0.0%
Rilbbph ($RILBBPH)8.5%7.6%7.3%7.0%7.3%


Top companies by Net Debt / EBITDA

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Monetbbph ($MONETBBPH)9.8x16.3x27.4x140.3x-
Indbulbbph ($INDBULBBPH)4.3x4.8x5.5x9.6x-
Jklakbbph ($JKLAKBBPH)2.1x2.3x5.3x5.5x-
Asleyf ($ASLEYF)2.5x5.0x17.8x5.0x-
Rane Engine Valve ($RANENGIN)2.1x11.3x4.5x4.8x-
 
Median (15 companies)2.1x2.3x2.2x1.1x0.0x
Rilbbph ($RILBBPH)1.7x2.1x2.9x3.9x3.9x